Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | AGPAT2 | O15120 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | AR | P10275 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | NAMPT | P43490 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10284421 | 0.87 | POLB (0.40) | SMN1; SMN2POLBAGPAT2MAPTNPC1 | |
| SCHEMBL10249110 | 0.87 | SMN1; SMN2 (0.40) | SMN1; SMN2POLBAGPAT2MAPTNPC1 | |
| SCHEMBL10249150 | 0.86 | TLR8 (0.41) | SMN1; SMN2POLBAGPAT2MAPTNPC1 | |
| SCHEMBL10248957 | 0.85 | SMN1; SMN2 (0.43) | SMN1; SMN2POLBAGPAT2MAPTNPC1 | |
| SCHEMBL10249153 | 0.84 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBMAPTTP53HSD17B10 | |
| SCHEMBL10249144 | 0.84 | SMN1; SMN2 (0.38) | SMN1; SMN2POLBAGPAT2MAPTNPC1 | |
| SCHEMBL10252630 | 0.83 | POLB (0.40) | SMN1; SMN2POLBAGPAT2MAPTNPC1 | |
| SCHEMBL4452215 | 0.82 | AGPAT2 (0.47) | SMN1; SMN2POLBAGPAT2MAPTNPC1 | |
| SCHEMBL10249306 | 0.81 | SMN1; SMN2 (0.40) | SMN1; SMN2POLBAGPAT2MAPTNPC1 | |
| SCHEMBL10249343 | 0.81 | TSHR (0.42) | SMN1; SMN2POLBAGPAT2MAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273764-B2 | Fused heterocyclic compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-25 | — | — | US | disclosed |
| US-20120015975-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015975-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | C3AR1, C9, C5 | SMN1; SMN2 1524/4885POLB 4724/4885AGPAT2 3286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.